162 related articles for article (PubMed ID: 17673802)
1. Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type of the Canadian alteplase for stroke effectiveness study registry.
Libman R; Kwiatkowski T
Stroke; 2007 Sep; 38(9):e88. PubMed ID: 17673802
[No Abstract] [Full Text] [Related]
2. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
[TBL] [Abstract][Full Text] [Related]
3. Intravenous thrombolysis is feasible and safe in multiethnic Asian stroke patients in Singapore.
Sharma VK; Tsivgoulis G; Tan JH; Ong BK; Chan BP; Teoh HL
Int J Stroke; 2009 Oct; 4(5):320-1. PubMed ID: 19765117
[No Abstract] [Full Text] [Related]
4. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study.
Hill MD; Buchan AM;
CMAJ; 2005 May; 172(10):1307-12. PubMed ID: 15883405
[TBL] [Abstract][Full Text] [Related]
5. Intravenous alteplase at 0.6 mg/kg for acute stroke patients with basilar artery occlusion: the stroke acute management with urgent risk factor assessment and improvement (SAMURAI) Recombinant tissue plasminogen activator registry.
Miyagi T; Koga M; Shiokawa Y; Nakagawara J; Hasegawa Y; Furui E; Kimura K; Kario K; Okuda S; Yamagami H; Okada Y; Nezu T; Maeda K; Endo K; Minematsu K; Toyoda K
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1098-106. PubMed ID: 23063059
[TBL] [Abstract][Full Text] [Related]
6. Risk of symptomatic intracerebral hemorrhage after thrombolysis with rt-PA: the SEDAN score.
Brüning T; Al-Khaled M
CNS Neurosci Ther; 2015 Mar; 21(3):296-7. PubMed ID: 25622691
[No Abstract] [Full Text] [Related]
7. Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke.
Zhang B; Sun XJ; Ju CH
Eur Neurol; 2011; 65(3):170-4. PubMed ID: 21372577
[TBL] [Abstract][Full Text] [Related]
8. Thrombolysis for stroke: policy should be based on science, and not on politics, money or fear of malpractice.
Hoffman JR
Emerg Med Australas; 2006 Jun; 18(3):215-8. PubMed ID: 16712529
[No Abstract] [Full Text] [Related]
9. Cholesterol measured before stroke thrombolysis is not associated with tissue plasminogen activator-related hemorrhagic transformation.
Montaner J
Stroke; 2008 Jan; 39(1):e6. PubMed ID: 18048844
[No Abstract] [Full Text] [Related]
10. Doubts, fears and misconceptions. What is the future of thrombolysis in acute stroke?
Barber PA; Hill MD; Demchuk AM; Buchan AM
Can J Neurol Sci; 2000 Nov; 27(4):283-7. PubMed ID: 11097516
[TBL] [Abstract][Full Text] [Related]
11. Symptomatic intracerebral and systemic hemorrhage after stroke thrombolysis in patients taking ticagrelor.
Lo KY; Biby S; Sethi P; Campbell BC
Int J Stroke; 2016 Aug; 11(6):NP71-2. PubMed ID: 27145796
[No Abstract] [Full Text] [Related]
12. Brush sign on 3-T T2*-weighted MRI as a potential predictor of hemorrhagic transformation after tissue plasminogen activator therapy.
Terasawa Y; Yamamoto N; Morigaki R; Fujita K; Izumi Y; Satomi J; Harada M; Nagahiro S; Kaji R
Stroke; 2014 Jan; 45(1):274-6. PubMed ID: 24172577
[TBL] [Abstract][Full Text] [Related]
13. Should statins be paused or discontinued after thrombolysis or acute intracerebral hemorrhage? No!
Scheitz JF; Nolte CH; Endres M
Stroke; 2013 May; 44(5):1472-6. PubMed ID: 23444304
[No Abstract] [Full Text] [Related]
14. THRIVE score predicts ischemic stroke outcomes and thrombolytic hemorrhage risk in VISTA.
Flint AC; Faigeles BS; Cullen SP; Kamel H; Rao VA; Gupta R; Smith WS; Bath PM; Donnan GA;
Stroke; 2013 Dec; 44(12):3365-9. PubMed ID: 24072004
[TBL] [Abstract][Full Text] [Related]
15. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
[TBL] [Abstract][Full Text] [Related]
16. Intravenous thrombolysis in young stroke patients: results from the SITS-ISTR.
Toni D; Ahmed N; Anzini A; Lorenzano S; Brozman M; Kaste M; Mikulik R; Putaala J; Wahlgren N;
Neurology; 2012 Mar; 78(12):880-7. PubMed ID: 22402853
[TBL] [Abstract][Full Text] [Related]
17. Relationships between age, other predictive variables, and the 90-day functional outcome after intravenous thrombolysis for acute ischemic stroke.
Gunathilake R; Krishnamurthy V; Oldmeadow C; Kerr E; Padmakumar C; Attia J; Parsons M; Levi C
Int J Stroke; 2014 Oct; 9(7):E36-7. PubMed ID: 25231586
[No Abstract] [Full Text] [Related]
18. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
Seet RC; Rabinstein AA
Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
[TBL] [Abstract][Full Text] [Related]
19. A case-controlled comparison of thrombolysis outcomes between wake-up and known time of onset ischemic stroke patients.
Manawadu D; Bodla S; Jarosz J; Keep J; Kalra L
Stroke; 2013 Aug; 44(8):2226-31. PubMed ID: 23723307
[TBL] [Abstract][Full Text] [Related]
20. Improved prediction of poor outcome after thrombolysis using conservative definitions of symptomatic hemorrhage.
Gumbinger C; Gruschka P; Böttinger M; Heerlein K; Barrows R; Hacke W; Ringleb P
Stroke; 2012 Jan; 43(1):240-2. PubMed ID: 21998049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
